349 related articles for article (PubMed ID: 6705899)
1. [Cytochrome P-450: the effect of drugs and poisons].
Chekman IS; Grinevich AI
Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
[No Abstract] [Full Text] [Related]
2. [Effect of drugs and poisons on the synthesis and activity of microsomal enzymes participating in their metabolism].
Hanke J
Folia Med Cracov; 1980; 22(3-4):263-78. PubMed ID: 7026384
[No Abstract] [Full Text] [Related]
3. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
Wada O; Yano Y
Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
[No Abstract] [Full Text] [Related]
4. [Alcohol and enzyme induction].
Joly JG
Union Med Can; 1979 May; 108(5):576-84. PubMed ID: 42180
[No Abstract] [Full Text] [Related]
5. Studies on the molecular function of cytochrome P-450 during drug metabolism.
Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
[No Abstract] [Full Text] [Related]
6. [Effect of tobacco smoking on drug metabolism].
Stańkowska-Chomicz A
Pol Tyg Lek; 1982 Jul; 37(23):689-91. PubMed ID: 7177964
[No Abstract] [Full Text] [Related]
7. Effect of synergists on drug metabolism.
Hodgson E; Philpot RM; Baker RC; Mailman RB
Drug Metab Dispos; 1973; 1(1):391-401. PubMed ID: 4149410
[No Abstract] [Full Text] [Related]
8. Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11).
Klekotka PA; Halpert JR
Drug Metab Dispos; 1995 Dec; 23(12):1434-5. PubMed ID: 8689957
[No Abstract] [Full Text] [Related]
9. Metabolic capabilities of the human fetus: drug biotransformation.
Juchau MR
Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372
[No Abstract] [Full Text] [Related]
10. [Poisoning as toxic principle].
Siegers CP
Dtsch Med Wochenschr; 1978 May; 103(18):759-62. PubMed ID: 648343
[No Abstract] [Full Text] [Related]
11. Multiplicity of liver drug metabolizing enzymes.
Lu AY
Drug Metab Rev; 1979; 10(2):187-208. PubMed ID: 121803
[No Abstract] [Full Text] [Related]
12. [Role of cytochrome P-450 in mixed function oxidation and metabolism of anesthetics].
Shigematsu A; Takahashi S; Furukawa T
Masui; 1974 Feb; 23(2):89-98. PubMed ID: 4603810
[No Abstract] [Full Text] [Related]
13. [Multiple forms of cytochrome P450 in the liver mono-oxygenase system].
Angelov E
Eksp Med Morfol; 1984; 23(1):46-51. PubMed ID: 6381030
[No Abstract] [Full Text] [Related]
14. The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
Hines RN; Prough RA
J Pharmacol Exp Ther; 1980 Jul; 214(1):80-6. PubMed ID: 7391974
[No Abstract] [Full Text] [Related]
15. [Effect of phospholipids on cytochrome P-450 and reactions with its participation].
Metelitsa DI
Usp Sovrem Biol; 1982; 94(3):345-59. PubMed ID: 6760578
[No Abstract] [Full Text] [Related]
16. [The induction of microsomal cytochrome P-450 and its medical consequences].
Pfeil D; Friedrich J
Pharmazie; 1985 Apr; 40(4):217-21. PubMed ID: 3892550
[No Abstract] [Full Text] [Related]
17. Hepatic cytochrome P-450.
Paine AJ
Essays Biochem; 1981; 17():85-126. PubMed ID: 6795037
[No Abstract] [Full Text] [Related]
18. [Clinico-pharmacological aspects of enzyme induction].
Bartłomowicz B
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1430-3. PubMed ID: 3913943
[No Abstract] [Full Text] [Related]
19. Mechanisms of inhibition of drug metabolic reactions.
Gillette J; Sasame H; Stripp B
Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
[No Abstract] [Full Text] [Related]
20. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes].
Filimonova AA; Ziganshin AU; Ziganshina LE
Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
